Skip to content

PR-Web

Press releases worldwide

  • Home
  • Contact
  • Datenschutzerklärung
  • Legal notice

Author: Firma NovAliX

NovAliX expands cryo-electron microscopy (cryo-EM) capabilities for drug development offering

Posted on 18. May 202114. July 2021 by Firma NovAliX Posted in Research / Development Tagged customers, discovery, drugs, embedded, grid, mesh, micro, new, nmr, novalix, ray, research, thermo, water, with

Expansion includes acquisition of novel, high-resolution cryo-electron microscope – with micro electron diffraction (microED) capabilities for solving protein and small molecule structures NovAliX will further develop cryo-EM service offerings for pharmaceutical industry NovAliX, a drug discovery-focused Contract Research Organization (CRO), […]

Read More

NovAliX appoints Dr. Jerome Guillemont as head of drug discovery, alongside two new directors

Posted on 22. April 202114. July 2021 by Firma NovAliX Posted in General Tagged discovery, drugs, fgfr, galien, guillemont, hiv, mdr, medical, new, novalix, patients, research, strong, treatment, with

Founded in 2002 and based in Strasbourg, France, NovAliX is a drug discovery-focused CRO with several unique technologies. It employs 200 researchers, with capabilities combining chemistry and biophysics. NovAliX offers its clients original collaborative models and extensive services within the […]

Read More

Copyright 2016. All rights reserved.


Back To Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkRead more